GTS Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-198,300
Closed -$32.1M 2709
2024
Q3
$32.1M Buy
198,300
+41,600
+27% +$6.63M 0.07% 167
2024
Q2
$22.9M Sell
156,700
-238,300
-60% -$35.4M 0.05% 225
2024
Q1
$62.5M Buy
395,000
+23,200
+6% +$3.69M 0.11% 79
2023
Q4
$58.3M Sell
371,800
-14,700
-4% -$2.25M 0.1% 99
2023
Q3
$60.2M Buy
+386,500
New +$63.8M 0.11% 86

Other funds holding JNJ

GTS Securities's JNJ Position: Q1 2026 in Review

GTS Securities reduced its Johnson & Johnson (JNJ) stake by 65% in Q1 2026, selling an estimated $5.08M and leaving 11,972 shares worth $2.93M. The position accounts for 0.1% of the portfolio, ranked #133.

GTS Securities first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.3M in Q2 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • GTS Securities held 11,972 shares of Johnson & Johnson worth $2.93M as of Q1 2026.
  • GTS Securities sold 21,808 Johnson & Johnson shares in Q1 2026, an estimated $5.08M.
  • Johnson & Johnson made up 0.1% of GTS Securities's portfolio in Q1 2026, its #133 holding.
  • GTS Securities first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Johnson & Johnson position peaked at $24.3M in Q2 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.